1-20 of 37
Guido Forni
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1196: Identification of lung cancer associated oncoantigens as targets for active immunotherapy

Federica Riccardo, Elena Quaglino, Maddalena Arigoni, Elisabetta Ercole, Mannuela Iezzi, Dario L. Longo, Guido Forni, Federica Cavallo, Raffaele A. Calogero
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1196.
https://doi.org/10.1158/1538-7445.AM2012-1196
Published: 15 April 2012
View article titled, Abstract 1196: Identification of lung cancer associated oncoantigens as targets for active immunotherapy
Journal Articles

Abstract 3321: From mouse to humans: detecting preventing vaccination targets associated to breast cancer stem cells

Stefania Lanzardo, Laura Conti, Guido Forni, Daniela Cantarella, Federica Cavallo, Raffaele A. Calogero
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3321.
https://doi.org/10.1158/1538-7445.AM10-3321
Published: 15 April 2010
View article titled, Abstract 3321: From mouse to humans: detecting preventing vaccination targets associated to breast cancer stem cells
Journal Articles

A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins

Elena Quaglino, Cristina Mastini, Augusto Amici, Cristina Marchini, Manuela Iezzi, Stefania Lanzardo, Carla De Giovanni, Maura Montani, Pier-Luigi Lollini, Giuseppe Masucci, Guido Forni, Federica Cavallo
Journal: Cancer Research
Cancer Res (2010) 70 (7): 2604–2612.
https://doi.org/10.1158/0008-5472.CAN-09-2548
Published: 31 March 2010
View article titled, A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins
Open the PDF for A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins in another window
Includes: Supplementary data
Journal Articles

Interleukin-15 and Its Receptor Augment Dendritic Cell Vaccination against the neu Oncogene through the Induction of Antibodies Partially Independent of CD4 Help

Jason C. Steel, Charmaine A. Ramlogan, Ping Yu, Yoshio Sakai, Guido Forni, Thomas A. Waldmann, John C. Morris
Journal: Cancer Research
Cancer Res (2010) 70 (3): 1072–1081.
https://doi.org/10.1158/0008-5472.CAN-09-1301
Published: 31 January 2010
View article titled, Interleukin-15 and Its Receptor Augment Dendritic Cell Vaccination against the <em>neu</em> Oncogene through the Induction of Antibodies Partially Independent of CD4 Help
Open the PDF for Interleukin-15 and Its Receptor Augment Dendritic Cell Vaccination against the <em>neu</em> Oncogene through the Induction of Antibodies Partially Independent of CD4 Help in another window
Journal Articles

Theraputic effect of adenoviral vaccine expressing ErbB-2/neu on established mouse breast cancer

Masaki Terabe, JongMyun Park, Jason Steel, Guido Forni, Yoshio Sakai, John Morris, Jay Berzofsky
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 5302.
Published: 01 May 2008
View article titled, Theraputic effect of adenoviral vaccine expressing ErbB-2/neu on established mouse breast cancer
Journal Articles

Therapy of Advanced Established Murine Breast Cancer with a Recombinant Adenoviral ErbB-2/neu Vaccine

Jong Myun Park, Masaki Terabe, Jason C. Steel, Guido Forni, Yoshio Sakai, John C. Morris, Jay A. Berzofsky
Journal: Cancer Research
Cancer Res (2008) 68 (6): 1979–1987.
https://doi.org/10.1158/0008-5472.CAN-07-5688
Published: 13 March 2008
View article titled, Therapy of Advanced Established Murine Breast Cancer with a Recombinant Adenoviral ErbB-2/<em>neu</em> Vaccine
Open the PDF for Therapy of Advanced Established Murine Breast Cancer with a Recombinant Adenoviral ErbB-2/<em>neu</em> Vaccine in another window
Journal Articles

Requirement for IFN-γ, CD8+ T Lymphocytes, and NKT Cells in Talactoferrin-Induced Inhibition of neu+ Tumors

Michela Spadaro, Claudia Curcio, Atul Varadhachary, Federica Cavallo, Jose Engelmayer, Paul Blezinger, Federica Pericle, Guido Forni
Journal: Cancer Research
Cancer Res (2007) 67 (13): 6425–6432.
https://doi.org/10.1158/0008-5472.CAN-06-4080
Published: 06 July 2007
View article titled, Requirement for IFN-γ, CD8<sup>+</sup> T Lymphocytes, and NKT Cells in Talactoferrin-Induced Inhibition of neu<sup>+</sup> Tumors
Open the PDF for Requirement for IFN-γ, CD8<sup>+</sup> T Lymphocytes, and NKT Cells in Talactoferrin-Induced Inhibition of neu<sup>+</sup> Tumors in another window
Journal Articles

Induction of anti-tumor immune responses by DNA vaccines encoding tumor antigens targeted to professional antigen presenting cells

Arjen Sloots, Cristina Mastini, Florian Rohrbach, Claudia Curcio, Robert Weth, Elke Jager, Guido Forni, Federica Cavallo, Winfried Wels
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 1886.
Published: 01 May 2007
View article titled, Induction of anti-tumor immune responses by DNA vaccines encoding tumor antigens targeted to professional antigen presenting cells
Journal Articles

Peptide vaccine administered with a Toll-like receptor agonist and regulatory T cell depletion is effective for the prevention of spontaneous breast tumors

Pilar Nava-Parada, Guido Forni, Keith Knutson, Larry Pease, Esteban Celis
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 4906.
Published: 01 May 2007
View article titled, Peptide vaccine administered with a Toll-like receptor agonist and regulatory T cell depletion is effective for the prevention of spontaneous breast tumors
Journal Articles

Peptide Vaccine Given with a Toll-Like Receptor Agonist Is Effective for the Treatment and Prevention of Spontaneous Breast Tumors

Pilar Nava-Parada, Guido Forni, Keith L. Knutson, Larry R. Pease, Esteban Celis
Journal: Cancer Research
Cancer Res (2007) 67 (3): 1326–1334.
https://doi.org/10.1158/0008-5472.CAN-06-3290
Published: 05 February 2007
View article titled, Peptide Vaccine Given with a Toll-Like Receptor Agonist Is Effective for the Treatment and Prevention of Spontaneous Breast Tumors
Open the PDF for Peptide Vaccine Given with a Toll-Like Receptor Agonist Is Effective for the Treatment and Prevention of Spontaneous Breast Tumors in another window
Journal Articles

Immunosurveillance of Erbb2 Carcinogenesis in Transgenic Mice Is Concealed by a Dominant Regulatory T-Cell Self-Tolerance

Elena Ambrosino, Michela Spadaro, Manuela Iezzi, Claudia Curcio, Guido Forni, Piero Musiani, Wei-Zen Wei, Federica Cavallo
Journal: Cancer Research
Cancer Res (2006) 66 (15): 7734–7740.
https://doi.org/10.1158/0008-5472.CAN-06-1432
Published: 02 August 2006
View article titled, Immunosurveillance of <em>Erbb2</em> Carcinogenesis in Transgenic Mice Is Concealed by a Dominant Regulatory T-Cell Self-Tolerance
Open the PDF for Immunosurveillance of <em>Erbb2</em> Carcinogenesis in Transgenic Mice Is Concealed by a Dominant Regulatory T-Cell Self-Tolerance in another window
Journal Articles

p130Cas as a New Regulator of Mammary Epithelial Cell Proliferation, Survival, and HER2-Neu Oncogene–Dependent Breast Tumorigenesis

Sara Cabodi, Agata Tinnirello, Paola Di Stefano, Brigitte Bisarò, Elena Ambrosino, Isabella Castellano, Anna Sapino, Riccardo Arisio, Federica Cavallo, Guido Forni, Marina Glukhova, Lorenzo Silengo, Fiorella Altruda, Emilia Turco, Guido Tarone, Paola Defilippi
Journal: Cancer Research
Cancer Res (2006) 66 (9): 4672–4680.
https://doi.org/10.1158/0008-5472.CAN-05-2909
Published: 01 May 2006
View article titled, p130Cas as a New Regulator of Mammary Epithelial Cell Proliferation, Survival, and HER2-Neu Oncogene–Dependent Breast Tumorigenesis
Open the PDF for p130Cas as a New Regulator of Mammary Epithelial Cell Proliferation, Survival, and HER2-Neu Oncogene–Dependent Breast Tumorigenesis in another window
Includes: Supplementary data
Journal Articles

Mammary tumor cells disseminate during atypical hyperplasia in Her2-transgenic mice

Yves Huesemann, Jochen B. Geigl, Falk Schubert, Manfred Meyer, Elke Burghart, Guido Forni, Roland Eils, Piero Musiani, Gert Riethmueller, Christoph A. Klein
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 567–568.
Published: 15 April 2006
View article titled, Mammary tumor cells disseminate during atypical hyperplasia in Her2-transgenic mice
Journal Articles

Talactoferrin Alfa, a novel immunomodulatory agent with anti-cancer activity in phase II clinical trials.

Atul Varadhachary, Michela Spadaro, Jose Engelmayer, Claudia Curcio, Paul Blezinger, Margalit B. Mokyr, Yenyun Wang, Ve ’ted’ Valli, Guido Forni, Federica Pericle
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1311.
Published: 15 April 2006
View article titled, Talactoferrin Alfa, a novel immunomodulatory agent with anti-cancer activity in phase II clinical trials.
Journal Articles

Vaccination with trastuzumab epitope mimics leads to prolonged tumor-free survival in HER-2/neu transgenic mice

Angelika B. Riemer, Kira H. Brämswig, Elena Quaglino, Guido Forni, Hubert Pehamberger, Otto Scheiner, Christoph C. Zielinski, Erika Jensen-Jarolim
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 151–152.
Published: 15 April 2006
View article titled, Vaccination with trastuzumab epitope mimics leads to prolonged tumor-free survival in HER-2/neu transgenic mice
Journal Articles

Identification of new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention

Raffaele A. Calogero, Sr., Francesca Cordero, Jr., Silvia Saviozzi, Sr., Nicola Cirenei, Sr., Simona Rolla, Sr., Elena Quaglino, Sr., Guido Forni, Sr., Federica Cavallo, Sr.
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 163.
Published: 15 April 2006
View article titled, Identification of new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention
Journal Articles

A Single Vaccination with Polyomavirus VP1/VP2Her2 Virus-Like Particles Prevents Outgrowth of HER-2/neu–Expressing Tumors

Karin Tegerstedt, Jan Alvar Lindencrona, Claudia Curcio, Kalle Andreasson, Carl Tullus, Guido Forni, Tina Dalianis, Rolf Kiessling, Torbjörn Ramqvist
Journal: Cancer Research
Cancer Res (2005) 65 (13): 5953–5957.
https://doi.org/10.1158/0008-5472.CAN-05-0335
Published: 01 July 2005
View article titled, A Single Vaccination with Polyomavirus VP1/VP2Her2 Virus-Like Particles Prevents Outgrowth of HER-2/<em>neu</em>–Expressing Tumors
Open the PDF for A Single Vaccination with Polyomavirus VP1/VP2Her2 Virus-Like Particles Prevents Outgrowth of HER-2/<em>neu</em>–Expressing Tumors in another window
Journal Articles

Genetic immunization against rat HER2/neu in tumor challenge and spontaneous mouse tumor models

Pasquale Gallo, Sridhar Dharmapuri, Maurizio Nuzzo, Daniele Maldini, Barbara Cipriani, Guido Forni, Paolo Monaci
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 814.
Published: 01 May 2005
View article titled, Genetic immunization against rat HER2/neu in tumor challenge and spontaneous mouse tumor models
Journal Articles

Vaccination of rat HER-2/neu transgenic mice, with syngeneic rat HER-2/neu, but not with xenogenic human ErbB receptors, prevents the development of spontaneous mammary carcinomas

Laura Masuelli, Chiara Focaccetti, Vittore Cereda, Paola Trono, Florigio Lista, Domenico Vitolo, Matthias H. Kraus, Guido Forni, Raffaella Muraro, Andrea Modesti, Roberto Bei
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 814.
Published: 01 May 2005
View article titled, Vaccination of rat HER-2/neu transgenic mice, with syngeneic rat HER-2/neu, but not with xenogenic human ErbB receptors, prevents the development of spontaneous mammary carcinomas
Journal Articles

Iressa™ is a potent cytostatic agent in HER2/Neu over-expressing acinic cell adenocarcinoma and augments fas-mediated apoptosis through multiple effector mechanism(s)

Marie Patrice Piechocki, George H. Yoo, Fulvio Lonardo, Susan K. Dibbley, Guido Forni
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1271.
Published: 01 May 2005
View article titled, Iressa™ is a potent cytostatic agent in HER2/Neu over-expressing acinic cell adenocarcinoma and augments fas-mediated apoptosis through multiple effector mechanism(s)